Weekly digest – 03 to 09 August 2024

Clinical  ·  Weekly digest - 03 to 09 August 2024
Exelixis drops tissue factor-targeting ADC after deciding it’s no match for Tivdak

Weekly Digest – August 2024 Weekly Digest – August 2024 07 Aug 2024: Exelixis drops tissue factor-targeting ADC after deciding it’s no match for Tivdak Exelixis has decided to discontinue development of its tissue factor-targeting antibody-drug conjugate, XB002, after assessing […]

by Sandhya Ramalingam

Continue Reading
Regulatory  ·  Weekly digest - 03 to 09 August 2024
Salubris Biotherapeutics Announces European Medicines Agency Approval to Initiate a Phase 1 Clinical Trial of JK06, a 5T4-Targeted ADC, in Solid Tumors

Weekly Digest – August 2024 Weekly Digest – August 2024 05 Aug 2024: Salubris Biotherapeutics Announces European Medicines Agency Approval to Initiate a Phase 1 Clinical Trial of JK06, a 5T4-Targeted ADC, in Solid Tumors Salubris Biotherapeutics has received EMA […]

by Sandhya Ramalingam

Continue Reading
Page 2 of 2